The Global Peptide Receptor Radionuclide Therapy (PRRT) Industry is on the cusp of substantial growth, with a projected value of US$ 591.83 million in 2023. According to the latest market analysis, this figure is anticipated to soar to an impressive US$ 1.3 billion by 2033. The forecast also reveals a robust Compound Annual Growth Rate …